Orbofiban TFA is an orally active GPIIb/IIIa platelet receptor antagonist with inhibitory effects on platelet aggregation for the study of unstable coronary syndromes.
Molecular Weight:
475.42
Purity:
98.72%
Formula:
C19H24F3N5O6
Target:
Integrin
T61345L
* VAT and and shipping costs not included. Errors and price changes excepted